Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements6003Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4910Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10934 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 6003

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
MiaGB — Microbiome in Aging of Gut and Brain NCT07799402 · NCT07799402 Maladie d’Alzheimer Immunomodulation À vérifier RECRUITING The Microbiome in Aging Gut and Brain (MiaGB) Study is an observational st… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
MK-2214 NCT05466422 · A Study of MK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate… Maladie d’Alzheimer Thérapie génique Phase 1 COMPLETED Researchers want to know if the study treatment called MK-2214 works to sl… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
PFM — Probiotic Milk Drink for Gut and Brain Health in Older Adults a… NCT07800195 · NCT07800195 Maladie d’Alzheimer Immunomodulation Non applicable NOT_YET_RECRUITING This double-blind, randomized, placebo-controlled clinical trial will eval… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
Speech-Based Artificial Intelligence for Detection of Dementia in Dan… NCT07200739 · NCT07200739 Maladie d’Alzheimer Thérapie génique À vérifier NOT_YET_RECRUITING The goal of this observational study is to learn if an artificial intellig… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
Sudoscan NCT06292741 · Autonomic Involvement in Patient With Cognitive Decline Maladie d’Alzheimer À vérifier Non applicable RECRUITING Prospective interventional study with a device for comparing autonomic par… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
Supporting Our Caregivers In ADRD Learning (SOCIAL) NCT06276023 · NCT06276023 Maladie d’Alzheimer À vérifier Non applicable COMPLETED Building on limitations of prior research, the investigators developed the… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
T2:C100 NCT05644262 · LiBBY — Life's End Benefits of cannaBidiol and tetrahYdrocannabinol Maladie d’Alzheimer À vérifier Phase 2 COMPLETED This is a multicenter randomized double-blind placebo-controlled Phase 2 s… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
Terazosin (Hytrin) NCT07796308 · TAME-AD — Terazosin And Metabolic Engagement in Alzheimer's Disease Maladie d’Alzheimer À vérifier Phase 2 NOT_YET_RECRUITING The TAME-AD trial will be a randomized, double-blind, placebo-controlled P… À vérifier ClinicalTrials.gov 2026-09-03 16:31:06 Détail
AZD0328 NCT04810104 · PD-MIND — Parkinson's Disease With Mild Cognitive Impairment Treated With Nicoti… Maladie de Parkinson Traitement symptomatique Phase 2 WITHDRAWN To test for the first time the potential of a nicotinic agonist on cogniti… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
HIHA — DOES HIPPOTHERAPY HAVE AN EFFECT ON MOBILITY, GAIT, BALANCE AN… NCT07802509 · NCT07802509 Maladie de Parkinson Traitement symptomatique Non applicable RECRUITING The goal of this pilot randomized controlled trial is to investigate the e… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
IRL757 NCT07461220 · LIFT-PD — Safety and Tolerability of IRL757 in Participants With Parkinson's Dis… Maladie de Parkinson Traitement symptomatique · Thérapie génique Phase 1/2 RECRUITING This clinical trial's goal is to evaluate if the IRL757 is safe and has a… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
Levodopa NCT06234995 · Cortical Electrophysiology of Response Inhibition in Parkinson's Disease Maladie de Parkinson À vérifier Phase 4 RECRUITING Patients with Parkinson's Disease will be studied before, during, and afte… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
Natural History Protocol for Movement Disorders NCT05413291 · NCT05413291 Maladie de Parkinson Ralentissement de la progression · Thérapie génique À vérifier RECRUITING Background: A movement disorder is a condition that causes a person s body… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
Predicting Cognition After DBS for Parkinson's Disease 2 NCT06272968 · NCT06272968 Maladie de Parkinson À vérifier À vérifier ACTIVE_NOT_RECRUITING The aim of the study is to improve estimation of cognitive outcome after S… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
Psilocybin therapy NCT04932434 · PDP1 — Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease Maladie de Parkinson À vérifier Phase 2 COMPLETED The purpose of this study is to determine the safety, tolerability, and fe… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
VG081821AC NCT07725562 · VG081821AC Tablets for Early to Mid-stage Parkinson's Disease Maladie de Parkinson Traitement symptomatique Phase 2/3 RECRUITING This study is testing a new oral medication called VG081821AC to see if it… À vérifier ClinicalTrials.gov 2026-09-03 16:31:04 Détail
Brain-Computer Interface with FES and VR NCT06690931 · recoveriX PD — Neurofeedback Rehabilitation With FES and VR for PD Maladie de Parkinson Traitement symptomatique Non applicable COMPLETED recoveriX PRO system is a Brain-Computer Interface (BCI) device that combi… À vérifier ClinicalTrials.gov 2026-09-03 16:31:03 Détail
Cerebellothalamic optimized deep brain stimulation NCT06618157 · Connectomic Guided DBS for Parkinson's Disease Maladie de Parkinson Neuroprotection Non applicable ENROLLING_BY_INVITATION The objective of this research is to use advanced connectomic imaging mode… À vérifier ClinicalTrials.gov 2026-09-03 16:31:03 Détail
Effect on Parkinson's Disease After Therapeutic Induction of CranioSa… NCT01989013 · NCT01989013 Maladie de Parkinson Traitement symptomatique Non applicable ENROLLING_BY_INVITATION We are studying \& researching the effect of CranioSacral Integrative ther… À vérifier ClinicalTrials.gov 2026-09-03 16:31:03 Détail
Sacituzumab Tirumotecan NCT06170788 · TroFuse-007 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizuma… Maladie de Parkinson Thérapie génique Phase 3 RECRUITING Researchers are looking for new ways to treat metastatic cervical cancer.… À vérifier ClinicalTrials.gov 2026-09-03 16:31:03 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4910

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 Maladie rénale chronique Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… Environmental toxicology and pharmacology 2026-11-15 04:38:02 Source
Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 Source
Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 Source
Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 Cancer Immunomodulation Publication PubMed Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… Biomaterials 2026-11-15 04:37:50 Source
Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 Insuffisance cardiaque Neuroprotection · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… Bioactive materials 2026-11-15 04:37:50 Source
Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… DEN open 2026-11-15 04:37:50 Source
Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 Maladie coronarienne À vérifier Publication PubMed Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… DEN open 2026-11-15 04:37:45 Source
Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… International journal of cardiology 2026-11-15 04:37:45 Source
Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 Source
Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Thérapie cellulaire Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Annals of translational medicine 2026-11-15 04:37:41 Source
Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… Cartilage 2026-11-15 04:37:41 Source
Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 Source
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 Myasthénie À vérifier Publication PubMed Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 Source
Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 Myasthénie À vérifier Publication PubMed Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… ACS omega 2026-11-15 04:37:34 Source
Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 Myopathies À vérifier Publication PubMed Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… The lancet. Psychiatry 2026-11-15 04:37:30 Source
Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 Myopathies À vérifier Publication PubMed Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 Source
Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 Myopathies Traitement symptomatique Publication PubMed Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 Source
Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 Cancer Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… Cancer immunology research 2026-11-15 04:37:24 Source
Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 Cancer Immunomodulation Publication PubMed Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… Journal of biological engineering 2026-11-15 04:37:24 Source
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 Lupus À vérifier Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Leukemia 2026-11-15 04:37:24 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.